News | November 16, 2006

Prostate Cancer Patients Report Fewer Side Effects with IMRT than with Brachytherapy

In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT.
"Both treatments demonstrated excellent PSA outcomes (biochemical control) after treatment," said Thomas N. Eade, MBChB, a fellow in the department of radiation oncology at Fox Chase Cancer Center. "The patients who received IMRT tended to be older, but even with that factor, IMRT was better tolerated."
The study included 374 patients with low-risk prostate cancers treated at Fox Chase with either IMRT (216 patients) or I-125 seed brachytherapy (158 patients). Patients who received neoadjuvant hormones were excluded from the study. The IMRT dose ranged from 74 to 78 Gy. The implant dose was 145 Gy. IMRT patients were an average of three years older (median age 67.6 years compared to 64.7 years).
Serious long-term side effects were significantly higher in the I-125 patients, including urethral stricture (narrowing) and catheterization. Catheterization within the first three months was required in three of the IMRT patients and 11 of the I-125 patients. Only one IMRT patient and seven of the implant patients required catheterization more than three months after completing treatment.
"This study shows men treated with brachytherapy have an increased risk of long-term side effects with brachytherapy as compared to IMRT," Eade said. "Advances in technologies will continue to improve outcomes for both treatment modalities, but for now IMRT delivers excellent cancer control with fewer long-term problems."

Related Content

Technology | PACS Accessories | January 03, 2018
January 3, 2018 — medQ Inc. recently announced the launch of its Q/ris MIPS Reporting module.
Philips Expands Population Health Management Business With Acquisition of VitalHealth
News | Population Health | December 28, 2017
Philips recently announced that it acquired VitalHealth, a provider of cloud-based population health management...
News | Enterprise Imaging | December 21, 2017
Vital Images showcased enhancements to its enterprise imaging solutions at the Radiological Society of North America (...
Philips IntelliSpace Portal 10 Highlighted by New 3-D Modeling Application
Technology | Advanced Visualization | December 13, 2017
Philips announced the debut of IntelliSpace Portal 10, the latest edition of its comprehensive, advanced visualization...
Medexprim's Radiomics Enabler Goes Open Source
Technology | PACS Accessories | December 06, 2017
December 6, 2017 — Medexprim announced its Radiomics Enabler, meant to enhance medical images archives for research,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Ambra Health Joins Google Cloud Technology Partner Program
News | PACS Accessories | December 05, 2017
December 4, 2017 — Ambra Health recently announced a new relationship with Google Cloud.
Fujifilm Introduces Artificial Intelligence Initiative for U.S. Market at RSNA 2017
News | Artificial Intelligence | December 04, 2017
December 4, 2017 — Fujifilm Medical Systems U.S.A. Inc.
Change Healthcare and Zebra Medical Vision Bring Artificial Intelligence to Medical Imaging
News | Artificial Intelligence | December 04, 2017
December 4, 2017 — Change Healthcare and Zebra Medical Vision announced an agreement to create solutions that deliver
ScImage Announces PicomPassport
Technology | PACS Accessories | November 30, 2017
ScImage Inc. introduced PicomPassport at the Radiological Society of North America’s 103rd Annual Scientific Assembly,...
Overlay Init